Clinical Images: Intersection syndrome of the forearm

Abstract

in BCR signaling and antigen targeting. J Exp Med 1999;190:1549–60. 2. Liossis SN, Solomou EE, Dimopoulos MA, Panayiotidis P, Mavrikakis M, Sfikakis PP. B-cell kinase Lyn deficiency in patients with systemic lupus erythematosus. J Investig Med 2001;49:157–65. 3. Huck S, le Corre R, Youinou P, Zouali M. Expression of B cell receptor-associated signaling molecules in human lupus. Autoimmunity 2001;33:213–4. 4. Singh RA, Sodhi A. Expression and activation of lyn in macrophages treated in vitro with cisplatin: regulation by kinases, phosphatases and Ca2 /calmodulin. Biochim Biophys Acta 1998;1405: 171–9. 5. Parolini I, Sargiacomo M, Lisanti MP, Peschle C. Signal transduction and glycophosphatidylinositol-linked proteins (lyn, lck, CD4, CD45, G proteins, and CD55) selectively localize in Triton-insoluble plasma membrane domains of human leukemic cell lines and normal granulocytes. Blood 1996;87:3783–94. 6. Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby KL, Clark EA, et al. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 1998;8:497–508. 7. Kyo S, Sada K, Qu X, Maeno K, Miah SM, Kawauchi-Kamata K, et al. Negative regulation of Lyn protein-tyrosine kinase by c-Cbl ubiquitin-protein ligase in Fc RI-mediated mast cell activation. Genes Cells 2003;8:825–36. 8. Shao Y, Yang C, Elly C, Liu YC. Differential regulation of the B cell receptor-mediated signaling by the E3 ubiquitin ligase Cbl. J Biol Chem 2004;279:43646–53.